• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

mantle cell lymphoma (MCL) - Articles and news items


EC approves Revlimid for mantle cell lymphoma

Industry news / 15 July 2016 / Victoria White, Digital Content Producer

Celgene’s Revlimid (lenalidomide) has been approved by the EC for the treatment of adult patients with relapsed or refractory mantle cell lymphoma…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +